Rooyakkers A, Ye L, Cahn PE, Ruiz-Palacios GM, et al. Relative efficacy, safety, and immunogenicity analysis of two doses versus one dose of recombinant coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomized, double blinded phase 3 trial. Vaccine 2026;79:128424.
PMID: 41863180